MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jadohealth.2019.02.014

Медицинская библиотека · The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2019

Meningococcal Vaccination Among Adolescents in the United States: A Tale of Two Age Platforms.

Kurosky Samantha K, Esterberg Elizabeth, Irwin Debra E, Trantham Laurel, Packnett Elizabeth, Novy Patricia, Whelan Jane, Hogea Cosmina

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

PURPOSE: Despite recommended routine vaccination with meningococcal conjugate vaccine (MenACWY) at ages 11-12 years with a booster at age 16 years, national estimates indicate MenACWY uptake is lower in older adolescents than younger adolescents. This study aimed to identify factors associated with MenACWY uptake among adolescents.

METHODS

Commercial Claims and Encounters (CCAE) and Medicaid MarketScan Databases from 2011 to 2016 were retrospectively analyzed (2017) to determine receipt of ≥1 dose of MenACWY during early (10.5 through 13 years) and late (15.5 through 18 years) adolescence. Multivariable logistic regression and nonlinear decomposition analyses were used to identify factors associated with MenACWY vaccination, potential missed opportunities, and differences between age groups.

RESULTS

A larger proportion of younger adolescents than older adolescents received MenACWY: CCAE, 71.7% versus 48.9% (p < .001); Medicaid, 59.3% versus 31.8% (p < .001), respectively. In multivariable models (CCAE), older adolescents were less likely than younger ones to receive MenACWY (adjusted odds ratios [95% confidence intervals]: .68 [.67, .69]) and more likely to have a potential missed opportunity (1.27 [1.25, 1.28]). Decomposition results showed lower MenACWY uptake in older adolescents is largely attributed to fewer non-MenACWY vaccines received, fewer preventive care visits, and interaction with nonpediatric healthcare providers.

DISCUSSION: Missed opportunities and infrequent preventive care encounters contribute to lack of vaccination in younger and older adolescents. However, the disparity in uptake between the two age groups was largely attributable to differences in healthcare utilization, suggesting a need for unique strategies to increase uptake among older adolescents, such as solidifying a vaccination platform for ages 16-18 years through encouragement of annual preventive care visits.

Для цитирования: Kurosky Samantha K, Esterberg Elizabeth, Irwin Debra E, Trantham Laurel, Packnett Elizabeth, Novy Patricia, Whelan Jane, Hogea Cosmina. Meningococcal Vaccination Among Adolescents in the United States: A Tale of Two Age Platforms.. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 2019. DOI: 10.1016/j.jadohealth.2019.02.014.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.